作为肝细胞癌的新兴原因MASH:当前的知识和未来的前景
1Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California San Diego, La Jolla, CA, USA.
Molecular oncology
|June 14, 2024
概括
代谢功能障碍相关的脂肪肝疾病 (MAFLD) 驱动肝细胞癌 (HCC) 通过肝硬化. 了解MAFLD驱动的HCC需要更好的临床前模型来模拟人类疾病的进展和分子机制.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肝细胞癌 (HCC) 是一种快速生长和致命的癌症.
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是HCC的主要驱动因素,增加肝硬化风险.
- 肥胖的环境加剧肥胖和代谢综合征,使肝脏疾病的预后复杂化.
研究的目的:
- 审查关于脂肪组织,MAFLD驱动的HCC病因和MAFLD-HCC患者遗传突变的文献.
- 批判性地评估目前用于研究MAFLD驱动的HCC的动物模型.
- 解决临床前模型的需求,这些模型准确地回顾了人类MAFLD驱动的HCC.
主要方法:
- 文献综述侧重于脂肪组织,HCC病因和MAFLD-HCC中的遗传特征.
- 对于MAFLD驱动的HCC研究,对现有的动物模型进行批判性分析.
- 在临床前模型中检查人类测量测量和疾病进展.
主要成果:
- MAFLD是HCC发展的重要因素,通常与肝硬化有关.
- 目前的临床前模型往往无法完全复制人类MAFLD驱动的HCC特征.
- 在MAFLD-HCC患者中的基因突变特征是最近发现的一个领域.
结论:
- 有效的临床前模型对于理解MAFLD驱动的HCC分子机制至关重要.
- 需要进一步开发模拟人类疾病的模型.
- 对脂肪组织,MAFLD病因和遗传突变的研究是推动MAFLD-HCC理解的关键.
关键词:
压力ERER压力ERER压力肝细胞癌是肝细胞癌.马什 (MASH) 是一个非常重要的产品.遗传突变是一种基因突变.这是一种炎症炎症炎症炎症.脂肪毒性 脂肪毒性 脂肪毒性代谢综合征代谢综合征肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
36.0K
相关概念视频
01:20Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K